Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Cash from Operations Growth (1y) (2010 - 2026)

Analysis

Thermo Fisher Scientific (TMO) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 51.89%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 14.65%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 43.37%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -14.10%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 42.90%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -2.84%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -15.28%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 14.53%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -4.15%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 39.29%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 51.89%
Mar 28, 2026 64.87%
Dec 31, 2025 5.08%
Sep 27, 2025 3.37%
Jun 28, 2025 -28.62%
Mar 29, 2025 -42.21%
Dec 31, 2024 -11.63%
Sep 28, 2024 -10.27%
Jun 29, 2024 27.27%
Mar 30, 2024 71.60%
Dec 31, 2023 6.77%
Sep 30, 2023 24.63%
Jul 1, 2023 0.79%
Apr 1, 2023 -66.89%
Dec 31, 2022 41.92%
Oct 1, 2022 -26.91%
Jul 2, 2022 -31.39%
Apr 2, 2022 11.32%
Dec 31, 2021 -26.42%
Oct 2, 2021 -2.14%